Jeffrey L. Rutherford - Jan 30, 2023 Form 4 Insider Report for DIEBOLD NIXDORF, Inc (DBD)

Role
EVP and CFO
Signature
Jonathan B. Leiken, Attorney-in-fact for Jeffrey L. Rutherford
Stock symbol
DBD
Transactions as of
Jan 30, 2023
Transactions value $
-$11,417
Form type
4
Date filed
2/1/2023, 05:02 PM
Previous filing
May 13, 2022
Next filing
Feb 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DBD Common Shares Tax liability -$11.4K -4.96K -1.11% $2.30 442K Jan 30, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding DBD Non-Qualified Stock Option 68.6K Jan 30, 2023 Common Shares 68.6K $4.08 Direct F3
holding DBD Non-Qualified Stock Option 18.9K Jan 30, 2023 Common Shares 18.9K $11.96 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld pursuant to exercise of tax withholding right under the 2017 Equity and Performance Incentive Plan - Restricted Share Award
F2 Number includes restricted stock units.
F3 Granted under the 2017 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.